Inventor · disambiguated record
Joseph W. Epstein
Also filed as: EPSTEIN JOSEPH W · EPSTEIN JOSEPH WILLIAM
48 granted patents·9 pending applications·1,129 citations·filing 1976–2020
99Inventor score
Top patents by PatentIndex Score
57 records- 0197US4131611AAzabicyclohexanesAMERICAN CYANAMID CO·Filed 1977·Granted Dec 26, 1978·70 cites·69 claims
- 0297US4118417AProcess for resolving cis-1-substituted phenyl-1,2-cyclopropanedicarboxylic acidsAMERICAN CYANAMID CO·Filed 1977·Granted Oct 3, 1978·46 cites·3 claims
- 0396US6372919B1(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agentDOV PHARMACEUTICAL INC·Filed 2001·Granted Apr 16, 2002·87 cites·15 claims
- 0496US4435419AMethod of treating depression using azabicyclohexanesAMERICAN CYANAMID CO·Filed 1982·Granted Mar 6, 1984·94 cites·24 claims
- 0596US4231935A1-Phenyl-3-azabicyclo[3.1.0]hexanesAMERICAN CYANAMID CO·Filed 1978·Granted Nov 4, 1980·50 cites·29 claims
- 0696US4088652AAcylazabicyclohexanesAMERICAN CYANAMID CO·Filed 1976·Granted May 9, 1978·52 cites·9 claims
- 0795US4196120AAzabicyclohexanes, method of use and preparation of the sameAMERICAN CYANAMID CO·Filed 1978·Granted Apr 1, 1980·44 cites·5 claims
- 0894US6716868B2(-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitorDOV PHARMACEUTICAL INC·Filed 2003·Granted Apr 6, 2004·41 cites·3 claims
- 0991US9205074B21-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersNEUROVANCE INC·Filed 2014·Granted Dec 8, 2015·9 cites·24 claims
- 1091US8877798B21-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersNEUROVANCE INC·Filed 2013·Granted Nov 4, 2014·11 cites·27 claims
- 1191US6569887B2(−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptakeDOV PHARMACEUTICALS INC·Filed 2001·Granted May 27, 2003·41 cites·19 claims
- 1291US6204284B1Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependenciesAMERICAN CYANAMID CO·Filed 1995·Granted Mar 20, 2001·154 cites·24 claims
- 1390US8461196B21-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersSKOLNICK PHIL·Filed 2012·Granted Jun 11, 2013·12 cites·11 claims
- 1490US7098229B2(+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereofDOV PHARMACEUTICAL INC·Filed 2002·Granted Aug 29, 2006·32 cites·18 claims
- 1590US7081471B2(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitorDOV PHARMACEUTICAL INC·Filed 2004·Granted Jul 25, 2006·24 cites·4 claims
- 1689US7098230B2(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitorDOV PHARMACEUTICAL INC·Filed 2004·Granted Aug 29, 2006·20 cites·23 claims
- 1789US7041835B2(−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitorDOV PHARMACEUTICAL INC·Filed 2004·Granted May 9, 2006·23 cites·10 claims
- 1889US4544665A1-Aryl-3-azabicyclo[3.2.0]heptanesAMERICAN CYANAMID CO·Filed 1983·Granted Oct 1, 1985·22 cites·16 claims
- 1988US9737506B21-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersNEUROVANCE INC·Filed 2015·Granted Aug 22, 2017·5 cites·26 claims
- 2086US10039746B21-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2017·Granted Aug 7, 2018·3 cites·24 claims
- 2185US4904658ASubstituted-6H,8H-pyrimido-[1,2,3-cd]purine-8,10-(9H)-diones and substituted-6H,10H-pyrimido[1,2-cd]purin-10-onesAMERICAN CYANAMID CO·Filed 1988·Granted Feb 27, 1990·19 cites·17 claims
- 2285US4431661A5-Aryl-3-azabicyclo[3.2.0]heptan-6-one acetals, and analgesic use thereforAMERICAN CYANAMID CO·Filed 1981·Granted Feb 14, 1984·16 cites·24 claims
- 2384US4847256A4,5-dihydro and 4,5,6,7-tetrahydropyrazolo(1,5-A)-pyrimidinesAMERICAN CYANAMID CO·Filed 1986·Granted Jul 11, 1989·34 cites·15 claims
- 2484US4529736A3a-(Substituted phenyl)-2,3,3a,4,7,7a-hexahydro[or 3a-(substituted-phenyl)octahydro]-4,7-alkano-1H-isoindoles for treating depression in warm-blooded animalsAMERICAN CYANAMID CO·Filed 1983·Granted Jul 16, 1985·15 cites·24 claims
- 2581US5482971ABeta3 -adrenergic agents and their use in pharmaceutical compositionsAMERICAN CYANAMID CO·Filed 1993·Granted Jan 9, 1996·24 cites·17 claims
- 2681US4977189ASubstituted guanidinedicarbonyl derivativesAMERICAN CYANAMID CO·Filed 1988·Granted Dec 11, 1990·18 cites·17 claims
- 2780US4963553A4-[(substituted) alkylcarbonyl]-4,5-dihydro- and -4,5,6,7-tetrahydro-7-[(substituted)phenyl]pyrazolo[1,5-a]pyrimidinesAMERICAN CYANAMID CO·Filed 1988·Granted Oct 16, 1990·14 cites·18 claims
- 2879US4168269ASubstituted thieno-benzodiazepinesAMERICAN CYANAMID CO·Filed 1978·Granted Sep 18, 1979·9 cites·10 claims
- 2978US5594027AAminocycloalkanobenzodioxoles as beta-3 selective adrenergic agentsAMERICAN CYANAMID CO·Filed 1995·Granted Jan 14, 1997·21 cites·48 claims
- 3078US5480908Aβ3 -adrenergic agents benzodioxole dicarboxylates and their use in pharmaceutical compositionsAMERICAN CYANAMID CO·Filed 1993·Granted Jan 2, 1996·16 cites·6 claims
- 3174US5219857AMethod of treating cognitive and related neural behavioral problemsAMERICAN CYANAMID CO·Filed 1992·Granted Jun 15, 1993·15 cites·8 claims
- 3274US5084457ABenzoylaminoquinazolinonesAMERICAN CYANAMID CO·Filed 1990·Granted Jan 28, 1992·14 cites·16 claims
- 3372US5968908ARestricted 9-cis retinoidsAMERICAN CYANAMID CO·Filed 1995·Granted Oct 19, 1999·15 cites·33 claims
- 3472US5510376AAminocycloalkanobenzodioxoles as beta-3 selective adrenergic agentsAMERICAN CYANAMID CO·Filed 1994·Granted Apr 23, 1996·24 cites·21 claims
- 3572US5126340A4-[(substituted)alkylcarbonyl]-4,5-dihydro and -4,5,6,7-tetrahydro-7-[(substituted)-phenyl]pyrazolo[1,5-a]pyrimidine-3-carbonitrilesAMERICAN CYANAMID CO·Filed 1990·Granted Jun 30, 1992·13 cites·10 claims
- 3671US2021023049A1Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric DisordersOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 3768US6784184B25-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferaseWYETH CORP·Filed 2002·Granted Aug 31, 2004·4 cites·36 claims
- 3867US2019070148A1Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric DisordersOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2018·Application pending·0 cites
- 3966US2009233978A1Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric DisordersSKOLNICK PHIL·Filed 2008·Application pending·0 cites
- 4063US6716862B25-(Substituted)-5-(substitutedsulfonyl or sulfanyl) thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferaseWYETH CORP·Filed 2002·Granted Apr 6, 2004·3 cites·25 claims
- 4160US4916137A5-(Substituted-amino)-8-(phenyl or substituted-phenyl)-3H,6H-1,4,5A,8A-tetraazaacenaphthylen-3-ones and treatment of neural behavior disordersAMERICAN CYANAMID CO·Filed 1988·Granted Apr 10, 1990·5 cites·18 claims
- 4260US2007082940A1Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disordersSKOLNICK PHIL·Filed 2006·Application pending·0 cites
- 4355US6861445B23-Substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferaseWYETH CORP·Filed 2003·Granted Mar 1, 2005·0 cites·8 claims
- 4454US6949661B23-substituted-3-(substitutedsulfonyl or sulfanyl) pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferaseWYETH CORP·Filed 2003·Granted Sep 27, 2005·0 cites·6 claims
- 4554US6740675B23-substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferaseWYETH CORP·Filed 2002·Granted May 25, 2004·0 cites·10 claims
- 4651US5606069Aβ3 -adrenergic agents, benzodioxole dicarboxylates and their use in pharmaceutical compositionsAMERICAN CYANAMID CO·Filed 1995·Granted Feb 25, 1997·4 cites·2 claims
- 4748US4888345A4,8-disubstituted-1,2-dihydro and 1,2,3,4-tetrahydroimidazo-[1,5-a] pyrimidinesAMERICAN CYANAMID CO·Filed 1988·Granted Dec 19, 1989·2 cites·16 claims
- 4848US2007225351A1Methods and compositions for controlling body weight and appetiteLIPPA ARNOLD S·Filed 2006·Application pending·0 cites
- 4947US2008234354A1Methods And Compositions For Controlling Body Weight And AppetiteLIPPA ARNOLD S·Filed 2007·Application pending·0 cites
- 5045US6605628B1Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferaseWYETH CORP·Filed 2002·Granted Aug 12, 2003·0 cites·20 claims
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Joseph W. Epstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →